Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Construction in Progress: 2021-2023

Historic Construction in Progress for Arrowhead Pharmaceuticals (ARWR) over the last 2 years, with Sep 2023 value amounting to $166.7 million.

  • Arrowhead Pharmaceuticals' Construction in Progress rose 195.63% to $166.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was $166.7 million, marking a year-over-year increase of 195.63%. This contributed to the annual value of $166.7 million for FY2023, which is 195.63% up from last year.
  • Per Arrowhead Pharmaceuticals' latest filing, its Construction in Progress stood at $166.7 million for Q3 2023, which was up 40.90% from $118.3 million recorded in Q2 2023.
  • Arrowhead Pharmaceuticals' 5-year Construction in Progress high stood at $166.7 million for Q3 2023, and its period low was $345,000 during Q3 2021.
  • Its 3-year average for Construction in Progress is $65.6 million, with a median of $56.4 million in 2022.
  • Data for Arrowhead Pharmaceuticals' Construction in Progress shows a peak YoY skyrocketed of 16,240.00% (in 2022) over the last 5 years.
  • Quarterly analysis of 3 years shows Arrowhead Pharmaceuticals' Construction in Progress stood at $2.2 million in 2021, then surged by 4,092.15% to $90.2 million in 2022, then surged by 195.63% to $166.7 million in 2023.
  • Its Construction in Progress stands at $166.7 million for Q3 2023, versus $118.3 million for Q2 2023 and $127.2 million for Q1 2023.